Growth Metrics

NovoCure (NVCR) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 NovoCure 1.90 Bn 1.47 Bn 135.13 Mn -107.28%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -107.28%
Dec 31, 2025 62.84%
Sep 30, 2025 -21.92%
Jun 30, 2025 -20.27%
Mar 31, 2025 11.46%
Dec 31, 2024 -40.02%
Sep 30, 2024 38.22%
Jun 30, 2024 41.87%
Mar 31, 2024 26.95%
Dec 31, 2023 -26.21%
Sep 30, 2023 -86.20%
Jun 30, 2023 -139.16%
Mar 31, 2023 -1,041.83%
Dec 31, 2022 -40.99%
Sep 30, 2022 -102.50%
Jun 30, 2022 -63.98%
Mar 31, 2022 -12.57%
Dec 31, 2021 -638.09%
Sep 30, 2021 -241.36%
Jun 30, 2021 -984.65%
Mar 31, 2021 -204.45%
Dec 31, 2020 15.42%
Sep 30, 2020 381.04%
Jun 30, 2020 230.31%
Mar 31, 2020 132.53%
Dec 31, 2019 127.25%
Sep 30, 2019 116.50%
Jun 30, 2019 91.81%
Mar 31, 2019 41.37%
Dec 31, 2018 -42.81%
Sep 30, 2018 -1.70%
Jun 30, 2018 26.75%
Mar 31, 2018 -14.85%
Dec 31, 2017 -118.61%
Sep 30, 2017 65.81%
Jun 30, 2017 47.86%
Mar 31, 2017 49.08%
Dec 31, 2016 278.64%
Sep 30, 2016 -29.22%
Jun 30, 2016 -38.34%
Mar 31, 2016 -52.27%
Dec 31, 2015 -193.10%
Sep 30, 2015 -42.05%